Has Tedd Ackerman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,235 in general payments to Tedd Ackerman, MD across 37 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tedd Ackerman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tedd Ackerman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tedd Ackerman, MD

Psychiatry · Holyoke, MANPI 1649369133

Payments from drug & device makers

$1,235in general payments, 2019–2025

Across 37 payments — averaging $33.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lundbeck LLC$335
Johnson & Johnson$238
Neurocrine Biosciences, Inc.$217
AbbVie$180
Alkermes, Inc.$85
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$84
plus $96 from 2 others

What the payments were for

Food & beverage$1,18896%
Education$474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lundbeck LLC	22	$335
Johnson & Johnson	4	$238
Neurocrine Biosciences, Inc.	2	$217
AbbVie	2	$180
Alkermes, Inc.	1	$85
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$84
E.r. Squibb & Sons, L.L.C.	1	$74
Takeda Pharmaceuticals U.S.A., Inc.	2	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,235 in reported general payments places this provider in the 85th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$94,929

Medicare patients

150

Services billed

1,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	37	$85,353
RexultiBrexpiprazole	25	$43,129
TrintellixVortioxetine Hydrobromide	48	$38,023
Lurasidone Hcl	43	$24,400
Doxepin Hcl	35	$7,076
Aripiprazole	21	$2,869
Lamotrigine	157	$2,275
Gabapentin	136	$1,999
Lorazepam	226	$1,952
Clonazepam	209	$1,918
Mirtazapine	99	$1,877
Duloxetine Hcl	58	$1,496
Armodafinil	19	$1,477
Trazodone Hcl	87	$1,410
Clozapine	48	$1,377

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$180	$85,35337 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$22	$38,02348 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Holyoke

Lee CohenBoston$7M
Dyanna DomiliciBoston$5.8M
Arkadiy StolyarBelmont$3.3M
Maurizio FavaBoston$2.8M
Marc ShayAmesbury$1.7M
Martha StarkNewton$1.6M
Hadine JoffeBoston$1.5M
Malini NairWinchester$1M
Xiaoduo FanWorcester$950K
Anthony RothschildWorcester$838K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →